Showing results (821-830 of 904) with videos related to
Sort By:
Pageof 91
ESMO Open|February 14, 2021
Two-month stop in mammographic screening significantly impacts on breast cancer stage at diagnosis and upfront treatment in the COVID eraA Toss, C Isca, M Venturelli, et al.Cardiovascular Diabetology|April 10, 2022
Liraglutide preserves CD34<sup>+</sup> stem cells from dysfunction Induced by high glucose exposureAnnalisa Sforza, Vera Vigorelli, Erica Rurali, et al.Anti-Cancer Agents in Medicinal Chemistry|March 11, 2016
Fab(nimotuzumab)-HYNIC-99mTc: Antibody Fragmentation for Molecular Imaging AgentsVictoria Calzada, María Fernanda García, Luis Michel Alonso-Martínez, et al.Pigment Cell & Melanoma Research|June 19, 2023
Melanoma and subcutaneous adipose tissue: Role of peritumoral adipokines in disease characterization and prognosisElisa Molinelli, Gabriele Ceccarelli, Sonia Fantone, et al.Vision (Basel, Switzerland)|June 1, 2022
Radial Peripapillary Capillary Plexus Perfusion and Endothelial Dysfunction in Early Post-SARS-CoV-2 InfectionMaria Cristina Savastano, Luca Santoro, Emanuele Crincoli, et al.Cell Death & Disease|August 25, 2017
Doxorubicin upregulates CXCR4 via miR-200c/ZEB1-dependent mechanism in human cardiac mesenchymal progenitor cellsSara Beji, Giuseppina Milano, Alessandro Scopece, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2008
Retrospective study of childhood ganglioneuromaBruno De Bernardi, Claudio Gambini, Riccardo Haupt, et al.Cancer Letters|August 1, 2016
Irreversible inhibition of Δ16HER2 is necessary to suppress Δ16HER2-positive breast carcinomas resistant to LapatinibMartina Tilio, Valentina Gambini, Junbiao Wang, et al.Molecules (Basel, Switzerland)|February 26, 2025
<sup>11</sup>C-Labeling of a Flavanone Extracted from a South American Native Species for Evaluation of Its Interaction with GSK-3βMaia Zeni, Maria Daniela Santi, Florencia Arredondo, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 19, 2002
Localized unresectable neuroblastoma: results of treatment based on clinical prognostic factorsA Garaventa, L Boni, M S Lo Piccolo, et al.Pageof 91